The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years old

Advertisement
The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years old
A boy receives the first dose of the Pfizer/BioNTech COVID-19 vaccine in Tegucigalpa, on September 25, 2021. ORLANDO SIERRA / AFP) (Photo by ORLANDO SIERRA/AFP/Getty Images

Hello,

Advertisement

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...


The Pfizer-BioNTech COVID-19 vaccine is 91% effective in 5- to 11-year-olds, new study results find

See the full story>>


The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years old
Dan Mendelson, Morgan Health's CEO. JPMorgan
The head of JPMorgan's new health bet reveals the 3 decisions that persuaded him to come aboard even after the bank's previous venture flopped

Check it out>>

Advertisement


The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years old
A customer buys onions at the "Central de Abasto" wholesale market in Mexico City on January 14, 2019. ALFREDO ESTRELLA / AFP) (Photo credit should read ALFREDO ESTRELLA/AFP/Getty Images
Salmonella linked to onions has infected more than 650 people in 37 states, CDC says

Read more now>>


More stories we're reading:


-Leah

{{}}